Climb Bio, Inc.
Biotechnology · WELLESLEY HILLS, MA
BiotechnologySEC Form D
Climb Bio, Inc. filed a Form D with the U.S. Securities and Exchange Commission on May 4, 2026, reporting $110,076,289 raised.
Incorporated in Delaware and based in WELLESLEY HILLS, MA, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Climb Bio, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Aoife BrennanExecutive Officer · Director
- Susan AltschullerExecutive Officer
- Perrin WilsonExecutive Officer
- Judith DunnDirector
- Stephen ThomasDirector
- Douglas WilliamsDirector
- Alexander (Bo) ComboDirector
- Andrew LevinDirector
- Kimberlee DrapkinDirector
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised